cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase

María A. Moro, Rachel J. Russell, Selim Cellek, Ignacio Lizasoain, Yunchao Su, Victor M. Darley-Usmar, Marek W. Radomski, Salvador Moncada

Research output: Contribution to journalArticle

399 Citations (Scopus)

Abstract

The L-arginine:nitric oxide (NO) pathway is believed to exert many of its physiological effects via stimulation of the soluble guanylyl cyclase (SGC); however, the lack of a selective inhibitor of this enzyme has prevented conclusive demonstration of this mechanism of action. We have found that the compound 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) inhibits the elevation of cGMP induced by the NO donor S-nitroso-DL-penicillamine in human platelets and rat vascular smooth muscle (IC50 = 10-60 nM and <10 nM, respectively) and that this is accompanied by prevention of the platelet inhibitory and vasodilator actions of NO donors. ODQ also inhibited the antiaggregatory action of NO generated by the platelets but did not affect the action of prostacyclin or that of a cGMP mimetic. In addition, ODQ inhibited the vasodilator actions of endogenously released NO and of NO generated after induction of NO synthase in vascular preparations. It did not, however, affect the increase in vascular smooth muscle cGMP or the dilatation induced by atrial natriuretic factor. ODQ had no effect on NO synthase activity, nor did it react with NO. It did, however, potently (IC50 ≃ 10 nM) inhibit the activity of the SGC in cytosol obtained from crude extract of rat aortic smooth muscle. Thus ODQ prevents the actions of NO on platelets and vascular smooth muscle through its potent inhibitory effect on the SGC.

Original languageEnglish (US)
Pages (from-to)1480-1485
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume93
Issue number4
DOIs
StatePublished - Feb 20 1996

Fingerprint

Blood Vessels
Nitric Oxide
Blood Platelets
Vascular Smooth Muscle
Vasodilator Agents
Nitric Oxide Synthase
Inhibitory Concentration 50
Penicillamine
Atrial Natriuretic Factor
Enzyme Inhibitors
Epoprostenol
Complex Mixtures
Cytosol
Smooth Muscle
Arginine
Dilatation
Soluble Guanylyl Cyclase

ASJC Scopus subject areas

  • General

Cite this

cGMP mediates the vascular and platelet actions of nitric oxide : Confirmation using an inhibitor of the soluble guanylyl cyclase. / Moro, María A.; Russell, Rachel J.; Cellek, Selim; Lizasoain, Ignacio; Su, Yunchao; Darley-Usmar, Victor M.; Radomski, Marek W.; Moncada, Salvador.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, No. 4, 20.02.1996, p. 1480-1485.

Research output: Contribution to journalArticle

Moro, María A. ; Russell, Rachel J. ; Cellek, Selim ; Lizasoain, Ignacio ; Su, Yunchao ; Darley-Usmar, Victor M. ; Radomski, Marek W. ; Moncada, Salvador. / cGMP mediates the vascular and platelet actions of nitric oxide : Confirmation using an inhibitor of the soluble guanylyl cyclase. In: Proceedings of the National Academy of Sciences of the United States of America. 1996 ; Vol. 93, No. 4. pp. 1480-1485.
@article{30c08feb34e1461f8ee4efc6b9dee4ca,
title = "cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase",
abstract = "The L-arginine:nitric oxide (NO) pathway is believed to exert many of its physiological effects via stimulation of the soluble guanylyl cyclase (SGC); however, the lack of a selective inhibitor of this enzyme has prevented conclusive demonstration of this mechanism of action. We have found that the compound 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) inhibits the elevation of cGMP induced by the NO donor S-nitroso-DL-penicillamine in human platelets and rat vascular smooth muscle (IC50 = 10-60 nM and <10 nM, respectively) and that this is accompanied by prevention of the platelet inhibitory and vasodilator actions of NO donors. ODQ also inhibited the antiaggregatory action of NO generated by the platelets but did not affect the action of prostacyclin or that of a cGMP mimetic. In addition, ODQ inhibited the vasodilator actions of endogenously released NO and of NO generated after induction of NO synthase in vascular preparations. It did not, however, affect the increase in vascular smooth muscle cGMP or the dilatation induced by atrial natriuretic factor. ODQ had no effect on NO synthase activity, nor did it react with NO. It did, however, potently (IC50 ≃ 10 nM) inhibit the activity of the SGC in cytosol obtained from crude extract of rat aortic smooth muscle. Thus ODQ prevents the actions of NO on platelets and vascular smooth muscle through its potent inhibitory effect on the SGC.",
author = "Moro, {Mar{\'i}a A.} and Russell, {Rachel J.} and Selim Cellek and Ignacio Lizasoain and Yunchao Su and Darley-Usmar, {Victor M.} and Radomski, {Marek W.} and Salvador Moncada",
year = "1996",
month = "2",
day = "20",
doi = "10.1073/pnas.93.4.1480",
language = "English (US)",
volume = "93",
pages = "1480--1485",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "4",

}

TY - JOUR

T1 - cGMP mediates the vascular and platelet actions of nitric oxide

T2 - Confirmation using an inhibitor of the soluble guanylyl cyclase

AU - Moro, María A.

AU - Russell, Rachel J.

AU - Cellek, Selim

AU - Lizasoain, Ignacio

AU - Su, Yunchao

AU - Darley-Usmar, Victor M.

AU - Radomski, Marek W.

AU - Moncada, Salvador

PY - 1996/2/20

Y1 - 1996/2/20

N2 - The L-arginine:nitric oxide (NO) pathway is believed to exert many of its physiological effects via stimulation of the soluble guanylyl cyclase (SGC); however, the lack of a selective inhibitor of this enzyme has prevented conclusive demonstration of this mechanism of action. We have found that the compound 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) inhibits the elevation of cGMP induced by the NO donor S-nitroso-DL-penicillamine in human platelets and rat vascular smooth muscle (IC50 = 10-60 nM and <10 nM, respectively) and that this is accompanied by prevention of the platelet inhibitory and vasodilator actions of NO donors. ODQ also inhibited the antiaggregatory action of NO generated by the platelets but did not affect the action of prostacyclin or that of a cGMP mimetic. In addition, ODQ inhibited the vasodilator actions of endogenously released NO and of NO generated after induction of NO synthase in vascular preparations. It did not, however, affect the increase in vascular smooth muscle cGMP or the dilatation induced by atrial natriuretic factor. ODQ had no effect on NO synthase activity, nor did it react with NO. It did, however, potently (IC50 ≃ 10 nM) inhibit the activity of the SGC in cytosol obtained from crude extract of rat aortic smooth muscle. Thus ODQ prevents the actions of NO on platelets and vascular smooth muscle through its potent inhibitory effect on the SGC.

AB - The L-arginine:nitric oxide (NO) pathway is believed to exert many of its physiological effects via stimulation of the soluble guanylyl cyclase (SGC); however, the lack of a selective inhibitor of this enzyme has prevented conclusive demonstration of this mechanism of action. We have found that the compound 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ) inhibits the elevation of cGMP induced by the NO donor S-nitroso-DL-penicillamine in human platelets and rat vascular smooth muscle (IC50 = 10-60 nM and <10 nM, respectively) and that this is accompanied by prevention of the platelet inhibitory and vasodilator actions of NO donors. ODQ also inhibited the antiaggregatory action of NO generated by the platelets but did not affect the action of prostacyclin or that of a cGMP mimetic. In addition, ODQ inhibited the vasodilator actions of endogenously released NO and of NO generated after induction of NO synthase in vascular preparations. It did not, however, affect the increase in vascular smooth muscle cGMP or the dilatation induced by atrial natriuretic factor. ODQ had no effect on NO synthase activity, nor did it react with NO. It did, however, potently (IC50 ≃ 10 nM) inhibit the activity of the SGC in cytosol obtained from crude extract of rat aortic smooth muscle. Thus ODQ prevents the actions of NO on platelets and vascular smooth muscle through its potent inhibitory effect on the SGC.

UR - http://www.scopus.com/inward/record.url?scp=0029928061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029928061&partnerID=8YFLogxK

U2 - 10.1073/pnas.93.4.1480

DO - 10.1073/pnas.93.4.1480

M3 - Article

C2 - 8643658

AN - SCOPUS:0029928061

VL - 93

SP - 1480

EP - 1485

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 4

ER -